Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer
Min Young Baek, Hee Kyung Ahn, Kyu Ree Park, Hwa-Sun Park, Shin Myung Kang, Inkeun Park, Young Saing Kim, Junshik Hong, Sun Jin Sym, Jinny Park, Jae Hoon Lee, Dong Bok Shin, Eun Kyung Cho
Korean J Intern Med. 2018;33(1):168-175.   Published online 2016 Apr 20     DOI: https://doi.org/10.3904/kjim.2015.158
Citations to this article as recorded by Crossref logo
Heterogeneity and Clinical Effect of Epidermal Growth Factor Receptor in Primary Lung and Brain Metastases of Nonsmall Cell Lung Cancer
Shuonan Xu, Jianfei Zhu, Daixing Zhong, Wenchen Wang, Yinsheng Wen, Lanjun Zhang, Tao Jiang
Journal of Surgical Research.2023; 283: 674.     CrossRef
Treatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea
Cliff Molife, Jae Min Cho, Jennifer Lapthorn, Min Ju Kang, Yulia D’yachkova, Sangmi Kim, Sam Colman, Saerom Kim, Agota Szende, Ji Hyun Park, Hee Kyung Ahn, Min Hee Hong, Kaisa-Leena Taipale, Hye Ryun Kim
Drugs - Real World Outcomes.2023; 10(1): 131.     CrossRef
Brain metastasis screening in the molecular age
Joanna K Tabor, Amanda Onoichenco, Vinayak Narayan, A Gabriella Wernicke, Randy S D’Amico, Morana Vojnic
Neuro-Oncology Advances.2023;[Epub]     CrossRef
Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis
Barbara Melosky, Kato Kambartel, Maik Häntschel, Margherita Bennetts, Dana J. Nickens, Julia Brinkmann, Antonin Kayser, Michael Moran, Federico Cappuzzo
Molecular Diagnosis & Therapy.2022; 26(1): 7.     CrossRef
First-Line Tyrosine Kinase Inhibitors Combined With Local Consolidative Radiation Therapy for Elderly Patients With Oligometastatic Non-Small Cell Lung Cancer Harboring EGFR Activating Mutations
Xiaolong Hu, Hongqi Li, Xiaoli Kang, Xuan Wang, Haifeng Pang, Chen Liu, Jianchun Zhang, Yingjie Wang
Frontiers in Oncology.2022;[Epub]     CrossRef
Afatinib in the treatment of brain metastases of lung cancer with one rare EGFR mutation: a two-case report
Liwei Sun, Bing Li, Bin Wang, Jinduo Li, Jing Li
Anti-Cancer Drugs.2022; 33(1): 112.     CrossRef
A Need for More Molecular Profiling in Brain Metastases
Erica Shen, Amanda E. D. Van Swearingen, Meghan J. Price, Ketan Bulsara, Roeland G. W. Verhaak, César Baëta, Brice D. Painter, Zachary J. Reitman, April K. S. Salama, Jeffrey M. Clarke, Carey K. Anders, Peter E. Fecci, C. Rory Goodwin, Kyle M. Walsh
Frontiers in Oncology.2022;[Epub]     CrossRef
The Effect of the Kirsten Rat Sarcoma Viral Oncogene Homolog (Kras) Proto-Oncogene, GTPase Genetic Polymorphism on the Safety and Efficacy of Bevacizumab Combination Treatment Regimens for Patients with Nonsquamous, Non-Small Cell Lung Cancer with Brain M
Zizheng Song, Guanying Ren, Xiaolei Wang, Ling Hu
Genetic Testing and Molecular Biomarkers.2022; 26(5): 290.     CrossRef
Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer
Wei Zhao, Wei Zhou, Li Rong, Mao Sun, Xing Lin, Lulu Wang, Shiqiang Wang, Ying Wang, Zhouguang Hui
Frontiers in Oncology.2022;[Epub]     CrossRef
Efficacy of immune checkpoint inhibitor therapy in EGFR mutation-positive patients with NSCLC and brain metastases who have failed EGFR-TKI therapy
Shujie Zhou, Fei Ren, Xiangjiao Meng
Frontiers in Immunology.2022;[Epub]     CrossRef
Mutational Analysis of EGFR Mutations in Non-Small Cell Lung Carcinoma—An Indian Perspective of 212 Patients
Amrit Kaur Kaler, Khushi Patel, Harshali Patil, Yash Tiwarekar, Bijal Kulkarni, Meenal Hastak, Nivetha Athikari, Samrudhi Rane, Ankita Nikam, Smita Umarji, Imran Shaikh, Sandeep Goyle, Rajesh Mistry
International Journal of Environmental Research and Public Health.2022; 20(1): 758.     CrossRef
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data
Lourdes Gutiérrez, Ana Royuela, Enric Carcereny, Rafael López-Castro, Delvys Rodríguez-Abreu, Bartomeu Massuti, José Luis González-Larriba, Rosario García-Campelo, Joaquim Bosch-Barrera, María Guirado, Carlos Camps, Manuel Dómine, Reyes Bernabé, Joaquín C
BMC Cancer.2021;[Epub]     CrossRef
Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature
Mina Karimpour, Reyhaneh Ravanbakhsh, Melika Maydanchi, Ali Rajabi, Faezeh Azizi, Ali Saber
Biomedicine & Pharmacotherapy.2021; 143: 112190.     CrossRef
Effects of single-nucleotide polymorphisms in the mTORC1 pathway on the risk of brain metastasis in patients with non-small cell lung cancer
Yiquan Xu, Yina Huang, Lihong Weng, Jiankun Zheng, Yi Huang, Ying Lin, Yunan Zhao, Hongru Li, Yusheng Chen
Journal of Cancer Research and Clinical Oncology.2020; 146(1): 273.     CrossRef
Establishment of a Prognostic Nomogram for Lung Adenocarcinoma with Brain Metastases
Zhangheng Huang, Yuexin Tong, Huifei Tian, Chengliang Zhao
World Neurosurgery.2020; 141: e700.     CrossRef
Implications of the autophagy core gene variations on brain metastasis risk in non-small cell lung cancer treated with EGFR-TKI*
Ye Yuan, Hu Han, Yu Jin, Xiao Zhou, Minxiao Yi, Yang Tang, Qianxia Li
Oncology and Translational Medicine.2020; 6(5): 185.     CrossRef
The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: a systematic review and meta-analysis
Wen-Ya Li, Ting-Ting Zhao, Hui-Mian Xu, Zhen-Ning Wang, Ying-Ying Xu, Yunan Han, Yong-Xi Song, Jian-Hua Wu, Hao Xu, Song-Cheng Yin, Xing-Yu Liu, Zhi-Feng Miao
BMC Cancer.2019;[Epub]     CrossRef
A Comprehensive Meta-Analysis of Association between EGFR Mutation Status and Brain Metastases in NSCLC
Li Tan, Yinying Wu, Xiaowei Ma, Yanli Yan, Shuai Shao, Jiaxin Liu, Hailin Ma, Rui Liu, Linyan Chai, Juan Ren
Pathology & Oncology Research.2019; 25(2): 791.     CrossRef
Platelet indices in non-small cell lung cancer patients with brain metastases
Ming-Ming Li, Xin Wang, Zhi-Yuan Yun, Rui-Tao Wang, Kai-Jiang Yu
Cancer Biomarkers.2019; 24(4): 515.     CrossRef
Multidisciplinary expert opinion on the treatment consensus for patients with EGFR mutated NSCLC with brain metastases
Santiago Ponce, Jordi Bruna, Oscar Juan, Rafael López, Alejandro Navarro, Ana Laura Ortega, Javier Puente, Eugènia Verger, Adela Bartolomé, Ernest Nadal
Critical Reviews in Oncology/Hematology.2019; 138: 190.     CrossRef
Paradoxical relationship between body mass index and bone mineral density in patients with non–small cell lung cancer with brain metastasis
Min Woo Nam, Jae Min Kim, Jin Hwan Cheong, Je Il Ryu, Myung-Hoon Han, Jung Weon Lee
PLOS ONE.2019; 14(6): e0218825.     CrossRef
Impact of EGFR mutation and ALK rearrangement on the outcomes of non–small cell lung cancer patients with brain metastasis
Suresh K Balasubramanian, Mayur Sharma, Vyshak A Venur, Philipp Schmitt, Rupesh Kotecha, Samuel T Chao, John H Suh, Lilyana Angelov, Alireza M Mohammadi, Michael A Vogelbaum, Gene H Barnett, Xuefei Jia, Nathan A Pennell, Manmeet S Ahluwalia
Neuro-Oncology.2019;[Epub]     CrossRef
Clinicopathologic and Imaging Features of Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
Subba R. Digumarthy, Dexter P. Mendoza, Eric W. Zhang, Jochen K. Lennerz, Rebecca S. Heist
Cancers.2019; 11(12): 2033.     CrossRef
The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study
Jung Soo Lee, Ji Hyung Hong, Der Sheng Sun, Hye Sung Won, Yeo Hyung Kim, Mi Sun Ahn, Seok Yun Kang, Hyun Woo Lee, Yoon Ho Ko
Scientific Reports.2019;[Epub]     CrossRef
MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer
Chunhua Wei, Ruiguang Zhang, Qian Cai, Xican Gao, Fan Tong, Jihua Dong, Yu Hu, Gang Wu, Xiaorong Dong
Aging.2019; 11(17): 6734.     CrossRef
IMP3 expression in NSCLC brain metastases demonstrates its role as a prognostic factor in non-neuroendocrine phenotypes
Alessandro Del Gobbo, Annamaria Morotti, Anna Eleonora Colombo, Valentina Vaira, Giulia Ercoli, Chiara Pesenti, Eleonora Bonaparte, Elena Guerini-Rocco, Andrea Di Cristofori, Marco Locatelli, Alessandro Palleschi, Stefano Ferrero
Medical Oncology.2018;[Epub]     CrossRef
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis
Wei-Yuan Chang, Yi-Lin Wu, Po-Lan Su, Szu-Chun Yang, Chien-Chung Lin, Wu-Chou Su, Jung Weon Lee
PLOS ONE.2018; 13(2): e0192161.     CrossRef
Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases
Shao-bo Ke, Hu Qiu, Jia-mei Chen, Wei Shi, Yong-shun Chen
Current Medical Science.2018; 38(6): 1062.     CrossRef
Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non–Small Cell Lung Cancer
Chul Kim, Chuong D. Hoang, Aparna H. Kesarwala, David S. Schrump, Udayan Guha, Arun Rajan
Journal of Thoracic Oncology.2017; 12(2): 179.     CrossRef
AXL–GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases
Xiaoliang Wu, Wenjuan Ma, Qianghua Zhou, Haijuan Yan, Zuan-Fu Lim, Mayan Huang, Chuangzhong Deng, Xingsu Yu, Huifang Su, Satoshi Komo, Haixia Yang, Xinke Zhang, Sijin Wen, Zhenfeng Zhang, Patrick C. Ma
Journal of Cancer Research and Clinical Oncology.2017; 143(10): 1947.     CrossRef
Patterns of metastatic progression after definitive radiation therapy for early-stage and locally advanced non-small cell lung cancer
Garrett L. Jensen, Chad Tang, Kenneth R. Hess, Zhongxing Liao, Daniel R. Gomez
Clinical & Experimental Metastasis.2017; 34(5): 315.     CrossRef
Brain metastases in non-small cell lung cancer patients on epidermal growth factor receptor tyrosine kinase inhibitors: symptom and economic burden
Ancilla W. Fernandes, Bingcao Wu, Ralph M. Turner
Journal of Medical Economics.2017; 20(11): 1136.     CrossRef
High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases
Mengxi Ge, Yingjie Zhuang, Xinli Zhou, Ruofan Huang, Xiaohua Liang, Qiong Zhan
Journal of Neuro-Oncology.2017; 135(2): 413.     CrossRef
Brain metastases in patients with non-small cell lung cancer: the role of mutated-EGFRs with an exon 19 deletion or L858R point mutation in cancer cell dissemination
Shih-Hsin Hsiao, Yu-Ting Chou, Sey-En Lin, Ru-Chun Hsu, Chi-Li Chung, Yu-Rung Kao, H. Eugene Liu, Cheng-Wen Wu
Oncotarget.2017; 8(32): 53405.     CrossRef
EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer
Pascale Tomasini, Cindy Serdjebi, Nataliya Khobta, Philippe Metellus, L’Houcine Ouafik, Isabelle Nanni, Laurent Greillier, Anderson Loundou, Frederic Fina, Celine Mascaux, Fabrice Barlesi
International Journal of Molecular Sciences.2016; 17(12): 2132.     CrossRef